EC Number   |
Substrates |
Organism |
Products |
Reversibility |
|---|
   2.4.1.92 | GM3(O-acetyl-(N-glycolyl)neuraminic acid) + UDP-N-acetyl-D-galactosamine |
less effective substrate |
Rattus norvegicus |
UDP + N-acetyl-D-galactosaminyl-GM3(O-acetyl-(N-glycolyl)neuraminic acid) |
- |
? |
| 2.4.1.92 | human glycoprotein hormone alpha-subunit + ? |
- |
Caenorhabditis elegans |
glycosylated human glycoprotein hormone alpha-subunit + ? |
- |
? |
| 2.4.1.92 | more |
acceptor specificity |
Rattus norvegicus |
? |
- |
? |
| 2.4.1.92 | more |
poor substrate: GM2-, GM1-, GD1b- and GT1-gangliosides and various ceramides |
Rattus norvegicus |
? |
- |
? |
| 2.4.1.92 | more |
no substrate: N-acetylglucosamine |
Rattus norvegicus |
? |
- |
? |
| 2.4.1.92 | more |
overview on substrate specificity |
Homo sapiens |
? |
- |
? |
| 2.4.1.92 | more |
no substrate: lactosylceramide, sialylparagloboside, GM1b(N-glycolylneuraminic acid), GD1a(N-acetylneuraminic acid), GT1b(N-acetylneuraminic acid), GQ1b(N-acetylneuraminic acid), GM1a(N-acetylneuraminic acid), GD1b(N-acetylneuraminic acid), globoside |
Mus musculus |
? |
- |
? |
| 2.4.1.92 | more |
no substrates are SM4-ganglioside, Gb3- and Gb4-ceramide |
Rattus norvegicus |
? |
- |
? |
| 2.4.1.92 | more |
no substrate: blood type H glycoprotein, deglucosylated bovine submaxillary mucin, various ceramides |
Rattus norvegicus |
? |
- |
? |
| 2.4.1.92 | more |
poor substrate: sialyllactose |
Mus musculus |
? |
- |
? |
